New Leqembi Subcutaneous Injection for Alzheimer’s Now in US
Eisai and Biogen have made Leqembi iqlik, a weekly 360 mg subcutaneous autoinjector, available in the U.S. as a...
High Court Approves MSD’s Successful Acquisition of Verona
MSD, the tradename of Merck & Co., will acquire Verona Pharma for $107 per American Depositary Share in a...
Equillium Announces Important Leadership, Corporate Updates
Equillium has restructured its leadership and governance while exiting a legacy collaboration to concentrate resources on a single internal...
Profusa Adds Leading French CLI Surgeon to Customer Base
Profusa has expanded its European footprint through a collaboration with Yann Gouëffic, professor of vascular surgery at Groupe Hospitalier...
Kraig Labs’ Breakthrough Unlocks Powerful Spider Silk Tech
Kraig Biocraft Laboratories has announced commercial-scale production of spider silk using genetically engineered silkworms, converting a long-celebrated biomaterial into...
Hutchmed Spotlights New Clinical Data for ESMO Congress 2025
HUTCHMED will take a broad slate of oncology data to ESMO 2025, headlined by the FRUSICA-2 registration study of...
Xilio to Present New Immunotherapy Data at SITC Meeting
Xilio Therapeutics will unveil new clinical and preclinical data at the Society for Immunotherapy of Cancer’s annual meeting on...
Ryoncil® Gets CMS J-Code, Boosting Patient Access
CMS has activated a permanent HCPCS J-code, J3402, for Mesoblast’s Ryoncil (remestemcel‑l‑rknd), effective October 1, 2025. The code creates...
A Powerful New Acquisition: Rockcliffe Labs Acquires Algae-C
Rockcliffe Labs has acquired a controlling interest in Algae-C for cash, making the Canadian algae-based discovery company a majority-owned...
The Truth About Rockcliffe Labs’ Acquisition of Algae-C
Rockcliffe Labs has acquired a controlling interest in Algae-C for cash, making Algae-C a majority-owned subsidiary with its legacy...